Bayer Investors Will Need Patience Despite Positive Earnings Surprise -- Market Talk

Dow Jones

2025/03/05

1326 GMT - Bayer's fourth-quarter results showed some positive surprises, but challenges to the company's underlying performance remain, Deutsche Bank analysts write. Fourth quarter sales, adjusted EBITDA and adjusted EPS exceeded expectations, largely due to slightly better-than-expected sales in all three units, along with lower corporate costs. However, underlying results reveal a different picture, with flat organic sales, a 22% decline in adjusted EBITDA and a 43% drop in adjusted EPS. 2025 guidance is not particularly encouraging, but the company's longer-term outlook and plans to address key issues offer some hope for future improvement, they add. "Investors will likely need to exercise patience as these measures take time to yield results." Deutsche Bank has a hold rating and 23 euro target price for Bayer's shares. Shares rise 3.5% at 24.35 euros. (dominic.chopping@wsj.com)

(END) Dow Jones Newswires

March 05, 2025 08:26 ET (13:26 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2517147219"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2517147219\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2517147219?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-05 21:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2517147219","market":"other","top_or_hot":-1,"title":"Bayer Investors Will Need Patience Despite Positive Earnings Surprise -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1326 GMT - Bayer's fourth-quarter results showed some positive surprises, but challenges to the company's underlying performance remain, Deutsche Bank analysts write. Fourth quarter sales, adjusted EBITDA and adjusted EPS exceeded expectations, largely due to slightly better-than-expected sales in all three units, along with lower corporate costs. However, underlying results reveal a different picture, with flat organic sales, a 22% decline in adjusted EBITDA and a 43% drop in adjusted EPS. 2025 guidance is not particularly encouraging, but the company's longer-term outlook and plans to address key issues offer some hope for future improvement, they add. \"Investors will likely need to exercise patience as these measures take time to yield results.\" Deutsche Bank has a hold rating and 23 euro target price for Bayer's shares. Shares rise 3.5% at 24.35 euros. (dominic.chopping@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 05, 2025 08:26 ET (13:26 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayer Investors Will Need Patience Despite Positive Earnings Surprise -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayer Investors Will Need Patience Despite Positive Earnings Surprise -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-03-05 21:26</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1326 GMT - Bayer's fourth-quarter results showed some positive surprises, but challenges to the company's underlying performance remain, Deutsche Bank analysts write. Fourth quarter sales, adjusted EBITDA and adjusted EPS exceeded expectations, largely due to slightly better-than-expected sales in all three units, along with lower corporate costs. However, underlying results reveal a different picture, with flat organic sales, a 22% decline in adjusted EBITDA and a 43% drop in adjusted EPS. 2025 guidance is not particularly encouraging, but the company's longer-term outlook and plans to address key issues offer some hope for future improvement, they add. \"Investors will likely need to exercise patience as these measures take time to yield results.\" Deutsche Bank has a hold rating and 23 euro target price for Bayer's shares. Shares rise 3.5% at 24.35 euros. (dominic.chopping@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 05, 2025 08:26 ET (13:26 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BAYRY","symbol_name":"Bayer A.G.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2517147219","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2517147219","pubTimestamp":1741181160,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1326 GMT - Bayer's fourth-quarter results showed some positive surprises, but challenges to the company's underlying performance remain, Deutsche Bank analysts write. Fourth quarter sales, adjusted EBITDA and adjusted EPS exceeded expectations, largely due to slightly better-than-expected sales in all three units, along with lower corporate costs. However, underlying results reveal a different picture, with flat organic sales, a 22% decline in adjusted EBITDA and a 43% drop in adjusted EPS. 2025 guidance is not particularly encouraging, but the company's longer-term outlook and plans to address key issues offer some hope for future improvement, they add. \"Investors will likely need to exercise patience as these measures take time to yield results.\" Deutsche Bank has a hold rating and 23 euro target price for Bayer's shares. Shares rise 3.5% at 24.35 euros. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BAYRY":"Bayer A.G.","ISBC":"投资者银行"},"translate_title":"尽管盈利令人意外，拜耳投资者仍需要耐心——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ISBC":1,"BAYRY":0.9},"content_text":"1326 GMT - Bayer's fourth-quarter results showed some positive surprises, but challenges to the company's underlying performance remain, Deutsche Bank analysts write. Fourth quarter sales, adjusted EBITDA and adjusted EPS exceeded expectations, largely due to slightly better-than-expected sales in all three units, along with lower corporate costs. However, underlying results reveal a different picture, with flat organic sales, a 22% decline in adjusted EBITDA and a 43% drop in adjusted EPS. 2025 guidance is not particularly encouraging, but the company's longer-term outlook and plans to address key issues offer some hope for future improvement, they add. \"Investors will likely need to exercise patience as these measures take time to yield results.\" Deutsche Bank has a hold rating and 23 euro target price for Bayer's shares. Shares rise 3.5% at 24.35 euros. (dominic.chopping@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 05, 2025 08:26 ET (13:26 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}